Galanthamine hydrobromide (Galantamine hydrobromide) is a selective, reversible, competitive, alkaloid AChE inhibitor, with an IC50 of 0.35 µM. Galanthamine hydrobromide is a potent allosteric potentiating ligand (APL) of human alpha3beta4, alpha4beta2, alpha6beta4 nicotinic receptors ( nAChRs). Galanthamine hydrobromide is developed for the research of Alzheimers disease (AD)[1][2][3].
Molecular Weight:
368.27
Purity:
99.93
CAS Number:
[1953-04-4]
Formula:
C17H22BrNO3
Target:
Cholinesterase (ChE),nAChR
Application Notes:
MCE Product type: Natural Products
* VAT and and shipping costs not included. Errors and price changes excepted
